Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ.

Lancet. 1996 Mar 23;347(9004):781-6.

PMID:
8622332
2.

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.

Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP.

Lancet. 1997 Jun 14;349(9067):1715-20.

PMID:
9193380
3.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI.

JAMA. 2002 Nov 20;288(19):2432-40.

PMID:
12435256
4.
5.

Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.

Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D, Huttunen JK.

Arch Intern Med. 1998 Mar 23;158(6):668-75.

PMID:
9521232
6.

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS.

Lancet. 2000 Oct 7;356(9237):1213-8.

PMID:
11072938
7.

Vitamin E supplementation and cardiovascular events in high-risk patients.

Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P.

N Engl J Med. 2000 Jan 20;342(3):154-60.

8.

Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.

Pietinen P, Rimm EB, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J.

Circulation. 1996 Dec 1;94(11):2720-7.

9.

Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).

DeMaio SJ, King SB 3rd, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN, Sgoutas DS.

J Am Coll Nutr. 1992 Feb;11(1):68-73.

PMID:
1541798
10.

Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris.

Rapola JM, Virtamo J, Ripatti S, Haukka JK, Huttunen JK, Albanes D, Taylor PR, Heinonen OP.

Heart. 1998 May;79(5):454-8.

11.

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM.

JAMA. 2008 Nov 12;300(18):2123-33. doi: 10.1001/jama.2008.600. Epub 2008 Nov 9.

12.

Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study.

Törnwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Taylor PR, Albanes D, Huttunen JK.

Eur Heart J. 2004 Jul;25(13):1171-8.

PMID:
15231376
13.

Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease.

McKechnie R, Rubenfire M, Mosca L.

J Lab Clin Med. 2002 Mar;139(3):133-9.

PMID:
11944023
15.

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Lancet. 2003 Jun 14;361(9374):2024-31.

PMID:
12814712
16.

Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.

Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK.

Lancet HIV. 2015 Feb;2(2):e52-63. doi: 10.1016/S2352-3018(14)00032-0. Epub 2015 Jan 9.

17.

Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.

Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators.

Eur Heart J. 2014 Jul 14;35(27):1801-8. doi: 10.1093/eurheartj/eht315. Epub 2013 Aug 29.

PMID:
23990605
18.

Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.

Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P.

Lancet. 2002 Mar 30;359(9312):1108-13.

PMID:
11943259
19.

The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM.

J Hypertens. 2007 Jan;25(1):227-34.

PMID:
17143195
20.

Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.

Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD.

J Am Coll Cardiol. 2005 Jul 5;46(1):166-72. Erratum in: J Am Coll Cardiol. 2011 Oct 18;58(17):1832.

Supplemental Content

Support Center